Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

129 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Awareness and Knowledge of Acute Exacerbation in Patients Dying with Interstitial Lung Disease: A Nationwide Survey.
Koyauchi T, Fujisawa T, Miyashita M, Mori M, Morita T, Yazawa S, Akiyama N, Hagimoto S, Matsuda Y, Tachikawa R, Yasui H, Suzuki M, Asai Y, Ono M, Kimura Y, Ohkouchi S, Tanino Y, Sugino K, Tateishi T, Kato M, Miyamoto A, Saito Y, Sakamoto S, Kono M, Yokomura K, Imokawa S, Sakamoto K, Waseda Y, Handa T, Hattori N, Anabuki K, Yatera K, Shundo Y, Hoshino T, Sakamoto N, Kondoh Y, Tomioka H, Tomii K, Inoue Y, Suda T. Koyauchi T, et al. Among authors: imokawa s. Ann Am Thorac Soc. 2024 Nov 8. doi: 10.1513/AnnalsATS.202405-495OC. Online ahead of print. Ann Am Thorac Soc. 2024. PMID: 39513985
Impact of end-of-life respiratory modalities on quality of dying and death and symptom relief in patients with interstitial lung disease: a multicenter descriptive cross-sectional study.
Koyauchi T, Suzuki Y, Sato K, Hozumi H, Karayama M, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Yokomura K, Imokawa S, Nakamura H, Morita T, Suda T. Koyauchi T, et al. Among authors: imokawa s. Respir Res. 2022 Apr 4;23(1):79. doi: 10.1186/s12931-022-02004-x. Respir Res. 2022. PMID: 35379240 Free PMC article.
Prognostic factors for primary Sjögren's syndrome-associated interstitial lung diseases.
Kamiya Y, Fujisawa T, Kono M, Nakamura H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Sumikawa H, Johkoh T, Yasui H, Hozumi H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Nakamura Y, Inui N, Suda T. Kamiya Y, et al. Among authors: imokawa s. Respir Med. 2019 Nov;159:105811. doi: 10.1016/j.rmed.2019.105811. Epub 2019 Nov 5. Respir Med. 2019. PMID: 31710871 Free article.
Prognostic significance of forced vital capacity decline prior to and following antifibrotic therapy in idiopathic pulmonary fibrosis.
Aono Y, Nakamura Y, Kono M, Nakamura H, Yokomura K, Imokawa S, Toyoshima M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Enomoto N, Fujisawa T, Inui N, Suda T. Aono Y, et al. Among authors: imokawa s. Ther Adv Respir Dis. 2020 Jan-Dec;14:1753466620953783. doi: 10.1177/1753466620953783. Ther Adv Respir Dis. 2020. PMID: 32928050 Free PMC article.
Prospective nationwide multicentre cohort study of the clinical significance of autoimmune features in idiopathic interstitial pneumonias.
Enomoto N, Homma S, Inase N, Kondoh Y, Saraya T, Takizawa H, Inoue Y, Ishii H, Taguchi Y, Izumi S, Yamano Y, Tanino Y, Nishioka Y, Toyoshima M, Yokomura K, Imokawa S, Koshimizu N, Sano T, Akamatsu T, Mukae H, Kato M, Hamada N, Chiba H, Akagawa S, Muro S, Uruga H, Matsuda H, Kaida Y, Kanai M, Mori K, Masuda M, Hozumi H, Fujisawa T, Nakamura Y, Ogawa N, Suda T. Enomoto N, et al. Among authors: imokawa s. Thorax. 2022 Feb;77(2):143-153. doi: 10.1136/thoraxjnl-2020-216263. Epub 2021 Jul 16. Thorax. 2022. PMID: 34272335
Chemotherapy for patients with advanced lung cancer with interstitial lung disease: a prospective observational study.
Koda K, Enomoto Y, Aoshima Y, Amano Y, Kato S, Hasegawa H, Matsui T, Yokomura K, Mochizuki E, Matsuura S, Koshimizu N, Morita M, Kojima S, Watanabe A, Oyama Y, Ikeda M, Kusagaya H, Uto T, Sato J, Imokawa S, Kono M, Hashimoto D, Kamiya Y, Toyoshima M, Asada K, Morita M, Mikamo M, Yasui H, Hozumi H, Karayama M, Suzuki Y, Furuhashi K, Fujisawa T, Enomoto N, Nakamura Y, Inui N, Suda T. Koda K, et al. Among authors: imokawa s. Ther Adv Chronic Dis. 2022 Jun 28;13:20406223221108395. doi: 10.1177/20406223221108395. eCollection 2022. Ther Adv Chronic Dis. 2022. PMID: 35782342 Free PMC article.
Prognostic Role of Interferon-λ3 in Anti-Melanoma Differentiation-Associated Gene 5-Positive Dermatomyositis-Associated Interstitial Lung Disease.
Fukada A, Fujisawa T, Hozumi H, Koda K, Akamatsu T, Oyama Y, Satake Y, Niwa M, Kaida Y, Matsuda H, Yokomura K, Koshimizu N, Toyoshima M, Imokawa S, Hashimoto D, Yoshida A, Gono T, Kuwana M, Yamano Y, Kondoh Y, Yamashita K, Maekawa M, Mori K, Inoue Y, Yasui H, Suzuki Y, Karayama M, Furuhashi K, Enomoto N, Inui N, Suda T. Fukada A, et al. Among authors: imokawa s. Arthritis Rheumatol. 2024 May;76(5):796-805. doi: 10.1002/art.42785. Epub 2024 Feb 6. Arthritis Rheumatol. 2024. PMID: 38146102
Predictors of poor clinical outcomes including in-hospital death and low ability to perform activities of daily living at discharge in hospitalized patients with chronic obstructive pulmonary disease exacerbation.
Murakami Y, Yasui H, Sato J, Uto T, Inui N, Suda T, Imokawa S. Murakami Y, et al. Among authors: imokawa s. Ther Adv Respir Dis. 2023 Jan-Dec;17:17534666231172924. doi: 10.1177/17534666231172924. Ther Adv Respir Dis. 2023. PMID: 37218674 Free PMC article.
129 results